InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,930.91
(
2.56%
)
US TECH 100
20,229.04
(
2.75%
)
Dow Jones
43,731.64
(
3.58%
)
Brent Oil
75.10
(
-0.39%
)
Bitcoin
75,846.51
(
9.42%
)
Post# of 253536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

urche

Send PM Follow Ignore
Followers 7
Posts 996
Boards Moderated 0
Alias Born 10/06/2004

urche

Re: None

Saturday, 02/07/2009 9:24:20 PM

Saturday, February 07, 2009 9:24:20 PM

Post# of 253536

What are the naysayers saying?

This has probably been addressed on the
BTV board, which I admit to being unable to keep up with.
But I am surprised at the drop in price on what appears to be a good deal for a phase 2 drug. And it was not really expected as far as I know, so the sell on the news investors shouldn't have built this into their strategy.

I would be interested in what the market sees as disappointing enough in this deal to send IDIX down on an up day for the market?

Urche
(cross posted on IDIX board which seems underutilized)
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up